Graft-versus-leukemia reactions in clinical bone marrow transplantation.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Leukemia and Lymphoma

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/10428199309148199PMID 8401179
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of effector cells of graft vs leukemia following allogeneic bone marrow transplantation in mice inoculated with murine B-cell leukemia

  2005cited by this paper
• Donor leukocyte infusions for chronic myeloid leukemia in relapse after allogeneic bone marrow transplantation [letter]

  1992cited by this paper
• Stimulation of NK cell, T cell, and monocyte functions by the novel immunomodulator Linomide after autologous bone marrow transplantation. A pilot study in patients with acute myeloid leukemia.

  1992cited by this paper
• Donor leukocyte infusions for chronic myeloid leukemia in relapse after allogeneic bone marrow transplantation.

  1992cited by this paper
• Immunotherapy of leukemia.

  1992cited by this paper
• Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia.

  1991cited by this paper
• Autologous Bone Marrow Transplantation in Hematological Malignancies

  1991cited by this paper
• Therapy of acute phase chronic myelogenous leukemia with intensive chemotherapy, blood cell autotransplant and cyclosporine A.

  1991cited by this paper
• Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia.

  1991cited by this paper
• Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells.

  1990cited by this paper
• Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation.

  1990cited by this paper
• Graft-versus-leukemia reactions after bone marrow transplantation.

  1990cited by this paper
• The graft-versus-leukemia (GVL) phenomenon: is GVL separable from GVHD?

  1990cited by this paper
• Specific recognition of human leukemic cells by allogeneic T cells: II. Evidence for HLA-D restricted determinants on leukemic cells that are crossreactive with determinants present on unrelated nonleukemic cells.

  1990cited by this paper
• Allogeneic bone marrow transplantation for leukemia with marrow grafts depleted of lymphocytes by counterflow centrifugation.

  1990cited by this paper
• Cyclosporine-induced graft-versus-host disease following autologous bone marrow transplantation in acute myeloid leukaemia.

  1990cited by this paper
• Hematologic and immunologic effects of the systemic administration of recombinant interleukin-2 after autologous bone marrow transplantation.

  1990cited by this paper
• Bone marrow transplantation using unrelated donors for patients with advanced leukemia or bone marrow failure.

  1990cited by this paper
• Induction of in vitro graft-versus-leukemia activity following bone marrow transplantation for chronic myeloid leukemia.

  1990cited by this paper
• Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia.

  1989cited by this paper
• Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial.

  1989cited by this paper
• Generation and characterization of IL-2-activated bone marrow cells as a potent graft vs tumor effector in transplantation.

  1989cited by this paper
• Regimen-related toxicity in patients undergoing bone marrow transplantation.

  1988cited by this paper
• Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation.

  1987cited by this paper
• Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia.

  1987cited by this paper
• T cell subsets and graft-versus-host disease.

  1987cited by this paper
• Cytotoxicity of interleukin 2-activated lymphocytes for leukemia and lymphoma cells

  1986cited by this paper
• Cytotoxicity of interleukin 2-activated lymphocytes for leukemia and lymphoma cells.

  1986cited by this paper
• Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse.

  1986cited by this paper
• REACTIVITY OF IN‐VITRO‐EXPANDED ALLOIMMUNE CYTOTOXIC T LYMPHOCYTES and Qa‐1‐SPECIFIC CYTOTOXIC T LYMPHOCYTES AGAINST AKR LEUKEMIA IN VIVO1

  1985cited by this paper
• Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1).

  1984cited by this paper
• Anti-tumor effects of allogeneic bone marrow transplantation in (NZB X NZW)F1 hybrids with spontaneous lymphosarcoma.

  1984cited by this paper
• Autologous bone marrow transplantation in hematological malignancies.

  1984cited by this paper
• Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation.

  1981cited by this paper
• Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.

  1979cited by this paper
• Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity

  1979cited by this paper
• Remission of relapsed leukaemia during a graft-versus-host reaction. A "graft-versus-leukaemia reaction" in man?

  1978cited by this paper
• REMISSION OF RELAPSED LEUKÆMIA DURING A GRAFT-VERSUS-HOST REACTION A "GRAFT-VERSUS-LEUKÆMIA REACTION" IN MAN?

  1978cited by this paper
• GRAFT VERSUS LEUKEMIA: III. Apparent Independent Antihost and Antileukemic Activity of Transplanted Immunocompetent Cells

  1973cited by this paper

• Beyond steroids: A systematic review and proposed solutions to managing acute graft-versus-host disease in adolescents and young adults.

  2021cites this paper
• Veto cells for safer nonmyeloablative haploidentical HSCT and CAR T cell therapy.

  2019cites this paper
• Cancer Immunotherapy: An Updated Overview of Current Strategies and Therapeutic Agents.

  2019cites this paper
• CTLA‐4 polymorphism rs231775: Influence on relapse and survival after allogeneic hematopoietic stem cell transplantation in childhood

  2019cites this paper
• Nature of Tumor Control by Permanently and Transiently Modified GD2 Chimeric Antigen Receptor T Cells in Xenograft Models of Neuroblastoma

  2014cites this paper
• Treatment of Advanced Leukemia in Mice with mRNA Engineered T Cells

  2011cites this paper
• A Randomized Controlled Multicenter Study Comparing Recombinant Interleukin 2 (rIL-2) in Conjunction With Recombinant Interferon Alpha (IFN-α) Versus no Immunotherapy for Patients With Malignant Lymphoma Postautologous Stem Cell Transplantation

  2010cites this paper
• Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect.

  2005cites this paper
• Haploidentical vs autologous hematopoietic stem cell transplantation in patients with acute leukemia beyond first remission

  2003cites this paper
• The third Fani Job Meeting in Hematology: cellular therapy and beyond

  2003cites this paper
• Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemia

  2002cites this paper
• Transgenic interleukin 2 secreted by CML dendritic cells stimulates autologous T(H)1 T cells.

  2001cites this paper
• The graft-versus-myeloma effect

  2000cites this paper
• Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial.

  2000cites this paper
• Long-term follow-up of relapsed acute leukemia treated with immunotherapy after allogeneic transplantation: the inseparability of graft-versus-host disease and graft-versus-leukemia, and the problem of extramedullary relapse.

  1999cites this paper
• Allogeneic peripheral blood progenitor cell transplantation in solid tumors.

  1999cites this paper
• Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation.

  1998cites this paper
• Graft-versus-myeloma

  1998cites this paper
• Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.

  1998cites this paper
• Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.

  1998cites this paper
• Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy

  1997cites this paper
• Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion.

  1997cites this paper
• Immunotherapy with recombinant human interleukin-2 and recombinant interferon-alpha in lymphoma patients postautologous marrow or stem cell transplantation.

  1997cites this paper
• Long-term safety of GM-CSF (molgramostim) administration after allogeneic bone marrow transplantation for hematologic malignancies: five-year follow-up of a double-blind randomized placebo-controlled study.

  1997cites this paper
• Sensitivity of secondary acute myeloid leukemia relapsing after allogeneic bone marrow transplantation to immunotherapy with interferon-α2b

  1997cites this paper
• Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: single-center experience of 32 adult patients

  1997cites this paper
• Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.

  1996cites this paper
• The novel immunomodulator, Linomide, stimulates interleukin-2-induced human natural killer (NK) cell and PHA-stimulated T cell proliferation from normal donors.

  1996cites this paper
• Melphalan alone prior to allogeneic bone marrow transplantation from HLA-identical sibling donors for hematologic malignancies: alloengraftment with potential preservation of fertility in women.

  1996cites this paper
• Idarubicin, high-dose cytarabine, and etoposide for induction of remission in acute leukemia.

  1996cites this paper
• High-dose hydroxyurea and G-CSF to collect Philadelphia-negative cells in chronic myeloid leukemia: preliminary results.

  1996cites this paper
• Campath-1G impairs human natural killer (NK) cell-mediated cytotoxicity.

  1996cites this paper
• Myelosuppressive chemotherapy to mobilize normal stem cells in chronic myeloid leukemia.

  1996cites this paper
• Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.

  1996cites this paper
• ASTA-Z 7557 impairs human natural killer (NK) cell activity.

  1996cites this paper
• T cell-depleted allogeneic bone marrow transplantation from a partially HLA-mismatched unrelated donor for progressive chronic lymphocytic leukemia and fludarabine-induced bone marrow failure.

  1996cites this paper
• Autologous transplantation with CD52 monoclonal antibody-purged marrow for acute lymphoblastic leukemia: long-term follow-up.

  1996cites this paper
• Granulocyte-macrophage colony-stimulating factor dependent monocyte-mediated cytotoxicity post-autologous bone marrow transplantation.

  1996cites this paper
• Failure of cyclosporine to induce graft-vs-host disease or graft-vs-leukemia after syngeneic bone marrow transplantation in mice.

  1996cites this paper
• Role of interleukin-2 in human hematological malignancies

  1995cites this paper
• Autologous bone marrow or peripheral blood stem cell transplantation followed by maintenance chemotherapy for adult acute lymphoblastic leukemia in first remission: 50 cases from a single center.

  1995cites this paper
• Bone marrow transplantation: current situation, complications and prevention.

  1995cites this paper
• Cytokine-mediated immunotherapy with or without donor leukocytes for poor-risk acute myeloid leukemia relapsing after allogeneic bone marrow transplantation.

  1995cites this paper
• The inhibition of lymphokine-activated killer cells in acute myeloblastic leukemia is mediated by transforming growth factor-beta 1.

  1995cites this paper
• Bone marrow transplantation for primary refractory acute leukaemia.

  1994cites this paper
• Unusual infections following allogeneic bone marrow transplantation for chronic lymphocytic leukemia.

  1994cites this paper